The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Daiichi Sankyo; Pfizer; Pfizer
Consulting or Advisory Role - Daiichi Sankyo; Genomic Health; Lilly; Novartis; Pfizer
Research Funding - G1 Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo
 
Travel, Accommodations, Expenses - Bayer

Fulvestrant in hormone receptor-positive advanced breast cancer: A UK retrospective multicenter study.
 
Karim Keshwani
No Relationships to Disclose
 
anna lerner
No Relationships to Disclose
 
Benjamin Sanderson
No Relationships to Disclose
 
Ruth E. Board
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
 
Michael Flynn
No Relationships to Disclose
 
Elizabeth Sharkey
No Relationships to Disclose
 
Alicia Frances Clare Okines
Honoraria - Roche
Research Funding - Pfizer (Inst)
 
Apostolos Konstantis
No Relationships to Disclose
 
Rebecca Roylance
No Relationships to Disclose
 
Daire Hanna
No Relationships to Disclose
 
Judy King
Consulting or Advisory Role - Eisai; Genomic Health; Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly; Roche
 
Ravindhi Murphy
No Relationships to Disclose
 
Farah Rehman
No Relationships to Disclose
 
Amy Elizabeth Guppy
Honoraria - Genomic Health; Roche
Speakers' Bureau - Genomic Health; Roche
 
Charlotte Westbury
No Relationships to Disclose
 
Elena Takeuchi
No Relationships to Disclose
 
Emma Spurrell
No Relationships to Disclose
 
Fharat Raja
Honoraria - AstraZeneca; Lilly; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Roche